Chemistry:Metamizil
Metamizil is a central anticholinergic drug and a tranquilliser with powerful sedative and hypnotic effects; it was studied during the Soviet era by Soviet scientists alongside amizil.[1][2]
Pharmacology
Metamizil acts as a muscarinic antagonist[3][4] and, at a dose of 2 mg/kg, blocks the symptoms of parkinsonism (hypokinesia, rigidity and tremor). Metamizil was used as premedication,[5][6] and is a strong sedative.[2][7][5]
The median lethal dose following intraperitoneal administration was 118 mg/kg (mouse).[8]
Uses
It has been suggested that it be used in the treatment of neuroses in dogs and humans.[7][9] Sometimes as premedication (as a tranquilliser).[5][6] As well as in the treatment of vascular parkinsonism[10][11] and cerebral palsy.[12]
Side effects
The reported side effects included dizziness and a dry mouth.[11]
References
- ↑ "[Method of treating parkinsonism with metamizil in combination with galanthamine (clinico-experimental basis)]". Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow) 85 (3): 376–381. 1985. PMID 3993298.
- ↑ 2.0 2.1 "[Effect of Amizil, Metamizil and Other Central Cholinolytics on the Convulsive Threshold of the Hippocampus and on the Threshold of the Activation Reaction]". Farmakologiia I Toksikologiia 27: 651–654. 1964. PMID 14321282.
- ↑ "[Effect of N- and M- cholinoblockaders on experimental epileptogenesis]". Biulleten' Eksperimental'noi Biologii I Meditsiny 95 (5): 23–25. May 1983. PMID 6133569.
- ↑ "[Effect of N- and M-cholinergic-potentiating and cholinergic-blocking agents on the epileptogenesis of a penicillin focus in the dorsal hippocampus]". Biulleten' Eksperimental'noi Biologii I Meditsiny 101 (4): 436–438. April 1986. PMID 2870750.
- ↑ 5.0 5.1 5.2 "[Analysis of the mutual potentiation of the tranquilizing effect of aminazin and metamizil in tympanoplasty in children]". Vestnik Otorinolaringologii 24: 44–50. 1962. PMID 13985983.
- ↑ 6.0 6.1 THE USE OF TRANQUILLISERS IN SURGERY (in Russian) Associate Professor I. A. Petukhov
- ↑ 7.0 7.1 "[Study of the therapeutic effect of metamizil in experimental neuroses in the dog]". Zhurnal Vysshei Nervnoi Deiatelnosti Imeni I P Pavlova 32 (4): 747–749. 1982. PMID 6890280.
- ↑ "Benzeneacetic acid, alpha-hydroxy-alpha-phenyl-, 2-(diethylamino)-1-methylethyl ester". PubChem. U.S. National Library of Medicine. https://pubchem.ncbi.nlm.nih.gov/compound/65527.
- ↑ "[On Tranquilizing Properties of 2 New Central Cholinolytics--Metamizil and Methyldiphacil--and Possible Application of Their Action]". Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow) 63: 582–590. 1963. PMID 14064772.
- ↑ "[Combined administration of cholinolytic metamizil and L-Dopa in vascular parkinsonism]". Klinicheskaia Meditsina (Mosk) 56 (9): 113–115. September 1978. PMID 703225.
- ↑ 11.0 11.1 "[Experience in treating vascular parkinsonism with metamysil]". Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow) 78 (3): 365–370. 1978. PMID 645311.
- ↑ "[Use of central (metamizil), peripheral (melliktin) cholinolytic and anticholinesterase (nivalin) preparations on combined therapy of cerebral paralysis in children]". Voprosy Psikhiatrii I Nevropatologii; Sbornik Trudov 11: 257–263. 1965. PMID 5883063.
